Crescita Therapeutics Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was CAD 6.51 million compared to CAD 2.95 million a year ago. Net loss was CAD 0.037 million compared to CAD 0.712 million a year ago.
For the six months, revenue was CAD 11.46 million compared to CAD 6.21 million a year ago. Net loss was CAD 0.511 million compared to CAD 1.15 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.06 a year ago.